Lista de obras - Carmine Stolfi - Dominio Público Uruguay

2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.

artículo científico publicado en 2011

A Functional Role for Interleukin-21 in Promoting the Synthesis of the T-Cell Chemoattractant, MIP-3α, by Gut Epithelial Cells

artículo científico publicado en 2006

A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease

scientific article published on 22 July 2020

A functional role for Smad7 in sustaining colon cancer cell growth and survival.

artículo científico publicado en 2014

Association Between Celiac Disease and Cancer

artículo científico publicado en 2020

Autocrine regulation of IL-21 production in human T lymphocytes

artículo científico publicado en 2008

BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis.

artículo científico publicado en 2017

Collagen matrix injection combined with flap repair for complex anal fistula

artículo científico publicado en 2012

Colorectal cancer chemoprevention by mesalazine and its derivatives.

artículo científico

Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures

scientific article published on 07 January 2021

Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21.

artículo científico publicado en 2006

Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid.

artículo científico publicado en 2007

Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut.

artículo científico publicado en 2014

Follistatin-like protein 1 sustains colon cancer cell growth and survival

artículo científico publicado en 2018

High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases

artículo científico publicado en 2013

IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis.

artículo científico publicado en 2007

IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa

scientific article published on 01 February 2008

Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide

scientific article published on 24 July 2019

Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages

artículo científico publicado en 2011

Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine.

artículo científico publicado en 2009

Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3.

artículo científico publicado en 2009

Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases

scientific article published on 01 August 2010

Interleukin-21 in cancer immunotherapy: Friend or foe?

artículo científico publicado en 2012

Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages.

artículo científico publicado en 2010

Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.

artículo científico publicado en 2009

Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue

artículo científico publicado en 2017

Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis

Involvement of interleukin-21 in the regulation of colitis-associated colon cancer

artículo científico publicado en 2011

Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferation.

artículo científico publicado en 2007

Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.

artículo científico publicado en 2013

Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer.

artículo científico

Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase

artículo científico publicado en 2008

Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation.

artículo científico publicado en 2018

Molecular targets of TRAIL-sensitizing agents in colorectal cancer

artículo científico publicado en 2012

NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals

artículo científico publicado en 2019

Neutrophil Extracellular Traps Sustain Inflammatory Signals in Ulcerative Colitis

artículo científico publicado en 2019

Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.

artículo científico publicado en 2015

Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells

artículo científico publicado en 2019

Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation.

artículo científico publicado en 2006

RORγt-Expressing Tregs Drive the Growth of Colitis-Associated Colorectal Cancer by Controlling IL6 in Dendritic Cells

artículo científico publicado en 2018

Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells

artículo científico publicado en 2020

Regulation of gut inflammation and th17 cell response by interleukin-21.

artículo científico publicado en 2008

Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System

scientific article published on 13 July 2020

Role of Interleukin-34 in Cancer

artículo científico publicado en 2020

Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer

artículo científico publicado en 2020

Role of TH17 cytokines in the control of colorectal cancer

artículo científico publicado en 2013

STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment

scholarly article by Federica Laudisi published in June 2018

Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression

artículo científico publicado en 2008

Smad7 expression in T cells prevents colitis-associated cancer.

artículo científico publicado en 2011

Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells.

artículo científico publicado en 2014

Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death.

artículo científico publicado en 2017

Smad7 positively regulates keratinocyte proliferation in psoriasis.

artículo científico publicado en 2017

Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth

artículo científico publicado en 2014

The AtMYB11 gene from Arabidopsis is expressed in meristematic cells and modulates growth in planta and organogenesis in vitro

artículo científico publicado en 2008

The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress-Driven Mucus Depletion and Exacerbates Intestinal Inflammation

artículo científico publicado en 2018

The dual role of Smad7 in the control of cancer growth and metastasis

artículo científico publicado en 2013

The dual role of interleukin-25 in the control of immune-mediated pathologies.

artículo científico publicado en 2011

The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway

artículo científico publicado en 2008

Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer.

artículo científico publicado en 2018

Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders?

artículo científico publicado en 2020

Lista de obras de Carmine Stolfi

2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.

A Functional Role for Interleukin-21 in Promoting the Synthesis of the T-Cell Chemoattractant, MIP-3α, by Gut Epithelial Cells

A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease

A functional role for Smad7 in sustaining colon cancer cell growth and survival.

Association Between Celiac Disease and Cancer

Autocrine regulation of IL-21 production in human T lymphocytes

BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis.

Collagen matrix injection combined with flap repair for complex anal fistula

Colorectal cancer chemoprevention by mesalazine and its derivatives.

Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures

Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21.

Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid.

Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut.

Follistatin-like protein 1 sustains colon cancer cell growth and survival

High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases

IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis.

IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa

Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide

Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages

Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine.

Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3.

Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases

Interleukin-21 in cancer immunotherapy: Friend or foe?

Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages.

Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.

Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue

Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis

Involvement of interleukin-21 in the regulation of colitis-associated colon cancer

Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferation.

Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.

Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer.

Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase

Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation.

Molecular targets of TRAIL-sensitizing agents in colorectal cancer

NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals

Neutrophil Extracellular Traps Sustain Inflammatory Signals in Ulcerative Colitis

Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.

Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells

Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation.

RORγt-Expressing Tregs Drive the Growth of Colitis-Associated Colorectal Cancer by Controlling IL6 in Dendritic Cells

Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells

Regulation of gut inflammation and th17 cell response by interleukin-21.

Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System

Role of Interleukin-34 in Cancer

Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer

Role of TH17 cytokines in the control of colorectal cancer

STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment

Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression

Smad7 expression in T cells prevents colitis-associated cancer.

Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells.

Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death.

Smad7 positively regulates keratinocyte proliferation in psoriasis.

Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth

The AtMYB11 gene from Arabidopsis is expressed in meristematic cells and modulates growth in planta and organogenesis in vitro

The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress-Driven Mucus Depletion and Exacerbates Intestinal Inflammation

The dual role of Smad7 in the control of cancer growth and metastasis

The dual role of interleukin-25 in the control of immune-mediated pathologies.

The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway

Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer.

Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders?